CIK 0001551152 · Large accelerated filer
AbbVie Inc.
Sign in to watch- Ticker
- ABBV
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 320375147
- Phone
- (847) 932-7900
- Business address
- 1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, IL, 60064
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $11,925,738
- in 1 filing
Net −$11,925,738. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-08 | WADDELL FREDERICK H Director | Grant or award | +1,118 | 30,076 | ||
| 2026-05-08 | FALK THOMAS J Director | Grant or award | +1,118 | 2,321 | ||
| 2026-05-08 | RAPP EDWARD J Director | Grant or award | +1,118 | 45,964 | ||
| 2026-05-08 | AUSTIN ROXANNE S Director | Grant or award | +1,118 | 39,576 | ||
| 2026-03-31 | Quaggin Susan E Director | Grant or award · Stock Equivalent Units | +71 | $217.49 | $15K | 784 |
| 2026-03-31 | Alpern Robert J Director | Grant or award · Stock Equivalent Units | +35 | $217.49 | $8K | 10,369 |
| 2026-03-31 | RAPP EDWARD J Director | Grant or award · Stock Equivalent Units | +155 | $217.49 | $34K | 28,865 |
| 2026-03-04 | Purdue David Ryan SVP, Controller | Sale | −5,230 | $233.56 | $1.2M | 2,654 |
| 2026-03-02 | Siatis Perry C EVP, GC AND SECRETARY | Sale 10b5-1 | −5,777 | $233.51 | $1.3M | 17,510 |
| 2026-03-02 | Siatis Perry C EVP, GC AND SECRETARY | Sale 10b5-1 | −10,291 | $234.66 | $2.4M | 7,219 |
| 2026-03-02 | Siatis Perry C EVP, GC AND SECRETARY | Sale 10b5-1 | −2,600 | $235.26 | $612K | 4,619 |
| 2026-02-27 | Purdue David Ryan SVP, Controller | Shares withheld for taxes | −2,108 | $232.08 | $489K | 8,468 |
| 2026-02-27 | Crum Demetris D EVP, CHIEF HR OFFICER | Shares withheld for taxes | −1,594 | $232.08 | $370K | 7,914 |
| 2026-02-27 | Purdue David Ryan SVP, Controller | Shares withheld for taxes | −2,692 | $232.08 | $625K | 7,884 |
| 2026-02-27 | Thakkar Roopal EVP, R&D and CSO | Shares withheld for taxes | −8,037 | $232.08 | $1.9M | 52,376 |
| 2026-02-27 | Siatis Perry C EVP, GC AND SECRETARY | Shares withheld for taxes 10b5-1 | −14,850 | $232.08 | $3.4M | 23,287 |
| 2026-02-27 | Reents Scott T EVP, CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −21,638 | $232.08 | $5.0M | 38,777 |
| 2026-02-27 | Donoghoe Nicholas EVP, CHIEF BUS/STRAT OFFICER | Shares withheld for taxes | −12,874 | $232.08 | $3.0M | 74,430 |
| 2026-02-27 | Stewart Jeffrey Ryan EVP, CHIEF COMMERCIAL OFFICER | Shares withheld for taxes | −23,812 | $232.08 | $5.5M | 83,171 |
| 2026-02-27 | Michael Robert A. CHAIRMAN OF THE BOARD AND CEO | Shares withheld for taxes | −36,523 | $232.08 | $8.5M | 178,737 |
Page 2 of 12 · 231 trades